# EDGAR Filing Document

**Accession Number:** 0000742112
**File Stem:** 0000876661-23-000121
**Filing Date:** 2023-2
**Character Count:** 6729
**Document Hash:** 61e891e6106d87169d6f0c9ebf0cb84c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000876661-23-000121.hdr.sgml**: 20230216

**ACCESSION NUMBER**: 0000876661-23-000121

**CONFORMED SUBMISSION TYPE**: 25-NSE

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230216

**DATE AS OF CHANGE**: 20230216

**EFFECTIVENESS DATE**: 20230216

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVACARE CORP
- **CENTRAL INDEX KEY:** 0000742112
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **IRS NUMBER:** 952680965
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 25-NSE
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15103
- **FILM NUMBER:** 23637364

**BUSINESS ADDRESS:**
- **STREET 1:** ONE INVACARE WAY
- **STREET 2:** P O BOX 4028
- **CITY:** ELYRIA
- **STATE:** OH
- **ZIP:** 44036
- **BUSINESS PHONE:** 4403296000

**MAIL ADDRESS:**
- **STREET 1:** ONE INVACARE WAY
- **STREET 2:** P O BOX 4028
- **CITY:** ELYRIA
- **STATE:** OH
- **ZIP:** 44036
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEW YORK STOCK EXCHANGE LLC
- **CENTRAL INDEX KEY:** 0000876661
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** NY

**FILING VALUES:**
- **FORM TYPE:** 25-NSE

**BUSINESS ADDRESS:**
- **STREET 1:** 11 WALL STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10005
- **BUSINESS PHONE:** 212-656-2060

**MAIL ADDRESS:**
- **STREET 1:** 11 WALL STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10005

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NEW YORK STOCK EXCHANGE INC
- **DATE OF NAME CHANGE:** 19910628

## Exhibit 99.25

```

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES

The New York Stock Exchange ('NYSE' or the 'Exchange') hereby notifies the Securities and Exchange Commission (the 'Commission') of its intention to remove the Common Shares, (the "Common Shares") of Invacare Corporation (the "Company") from listing and registration on the Exchange at the opening of business on February 27, 2023, pursuant to the provisions of Rule 12d2-2(b) because, in the opinion of the Exchange, the Common Shares are no longer suitable for continued listing and trading on the Exchange.

The Exchange reached its decision pursuant to Section 802.01D of the Listed Company Manual after the Company's s February 1, 2023 disclosure that the Company has filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas. In reaching its delisting determination, NYSE Regulation noted the uncertainty as to the ultimate effect of this process on the value of the Company's Common Shares. NYSE Regulation also noted that the Company's restructuring support agreement contemplates that the Company's outstanding Common Shares will be cancelled and extinguished without any distribution, and holders of the Company's Common Shares will not receive or retain any distribution or other value on account of their Common Shares

On February 1, 2023, the Exchange determined that the Common Shares of the Company should be suspended from trading and directed the preparation and filing with the Commission of this application for the removal of the Common Shares from listing and registration on the NYSE. The Company was notified on February 1, 2023.

The Company had a right to appeal to a Committee of the Board of Directors of the Exchange (the 'Committee') the determination to delist the Common Stock, provided it filed a written request for such a review with the Secretary of the Exchange within ten business days of receiving notice of the delisting determination. The Company did not file such request within the specified period. Consequently, all conditions precedent under SEC Rule 12d2-2(b) to the filing of this application have been satisfied.

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 25

### NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

**Commission File Number:** 001-15103

|  |  |
|:---|:---|
| Issuer:                                                                                                             | INVACARE CORP                                      |
| Exchange:                                                                                                           | NEW YORK STOCK EXCHANGE LLC                        |
| (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) |  |
| Address:                                                                                                            | One Invacare WayP.O. Box 4028, Elyria, OHIO, 44036 |
| Telephone number:                                                                                                   | (440) 329-6000                                     |
| (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)   |  |
| (Description of class of securities)                                                                                | Common Shares                                      |

---

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

- [ ] 17 CFR 240.12d2-2(a)(1)
- [ ] 17 CFR 240.12d2-2(a)(2)
- [ ] 17 CFR 240.12d2-2(a)(3)
- [ ] 17 CFR 240.12d2-2(a)(4)
- [x] Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
- [ ] Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

---

Pursuant to the requirements of the Securities Exchange Act of 1934, NEW YORK STOCK
EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing the Form 25 and has caused this notification to be signed on its
behalf by the undersigned duly authorized person.

| Date       | By   | Name             | Title               |
|:---|:---|:---|:---|
| 2023-02-16 |  | Nicolas Connolly | Analyst, Regulation |

Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR
240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB Number.